本页面由Tiger Trade Technology Pte. Ltd.提供服务

SPYRE THERAPEUTICS INC

80.45
-5.4500-6.34%
盘后:80.450.00000.00%19:30 EDT
成交量:144.11万
成交额:1.19亿
市值:74.25亿
市盈率:-40.03
高:85.32
开:85.12
低:80.45
收:85.90
52周最高:110.18
52周最低:18.71
股本:9,229.14万
流通股本:8,161.70万
量比:0.64
换手率:1.77%
股息:- -
股息率:- -
每股收益(TTM):-2.0100
每股收益(LYR):-1.9755
净资产收益率:-22.98%
总资产收益率:-19.81%
市净率:7.78
市盈率(LYR):-40.72

数据加载中...

2026/10/07

重要事件披露

Form 8-K - Current report
2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/10/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/08

重要事件披露

Form 8-K - Current report
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/26

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

重要事件披露

Form 8-K - Current report